Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine. (2018)
Attributed to:
Development and testing of novel recombinant pnemococcal glyconjugate vaccines
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2018.05.036
PubMed Identifier: 29778517
Publication URI: http://europepmc.org/abstract/MED/29778517
Type: Journal Article/Review
Volume: 36
Parent Publication: Vaccine
Issue: 26
ISSN: 0264-410X